Nanoscale products pose ethical, legal, and policy challenges to governing the use of products that integrate multiple mechanisms of therapeutic action.

Wearable or implantable devices enable employers to monitor health, productivity, and wellness of employees.

Minimizing and managing risks of ENMs means considering whether and when existing legal frameworks offer sufficient protection.

A form of aripiprazole places unique ethical and clinical demands on mental health professionals.

Ethical stakes include a psychiatrist’s care management responsibilities and burdens borne by family members over the course of the patient’s care.

Patients’ experiences of darkness and doubt can be replaced by a sense of buoyancy and lightness. Color and movement convey a patient’s sense of striving, aspiration, and optimism.

Growth in nano-based approaches to cancer diagnostics and therapeutics creates need to include nanotoxicology in medical education.

Physicians play important roles in community development when they seek to increase patients’ overall well-being through community engagement.

Social determinants and freedom situate newcomers’ capacity for well-being.

Changes to CB tax policy could promote engagement with public health departments, collaboration with community-based nonprofits, and greater focus on health equity.